| Primary |
| Anxiety |
19.0% |
| Dermatitis |
9.5% |
| Erythema Multiforme |
9.5% |
| Cataract Operation |
7.9% |
| Rash |
7.9% |
| Drug Exposure During Pregnancy |
6.3% |
| Product Used For Unknown Indication |
6.3% |
| Postoperative Care |
4.8% |
| Pseudomembranous Colitis |
4.8% |
| Arthropod Sting |
3.2% |
| Dandruff |
3.2% |
| Depression |
3.2% |
| Dermatitis Atopic |
3.2% |
| Anaesthesia |
1.6% |
| Blepharitis |
1.6% |
| Dermatitis Acneiform |
1.6% |
| Dermatitis Contact |
1.6% |
| Dermatomyositis |
1.6% |
| Eczema |
1.6% |
| Eye Operation |
1.6% |
|
| Toxic Anterior Segment Syndrome |
16.7% |
| Cleft Palate |
6.7% |
| Drug Ineffective |
6.7% |
| Maternal Drugs Affecting Foetus |
6.7% |
| Parkinson's Disease |
6.7% |
| Steroid Withdrawal Syndrome |
6.7% |
| Urticaria |
6.7% |
| Application Site Pain |
3.3% |
| Atrioventricular Block Complete |
3.3% |
| Bacteraemia |
3.3% |
| Dermatitis Acneiform |
3.3% |
| Drug Exposure During Pregnancy |
3.3% |
| Erythema |
3.3% |
| Erythema Multiforme |
3.3% |
| Expired Drug Administered |
3.3% |
| Genital Rash |
3.3% |
| Hypersensitivity |
3.3% |
| Maternal Exposure During Pregnancy |
3.3% |
| No Adverse Event |
3.3% |
| Pain In Jaw |
3.3% |
|
| Secondary |
| Anxiety |
20.8% |
| Dermatitis Atopic |
11.9% |
| Eczema Infantile |
8.9% |
| Dermatitis |
6.9% |
| Eczema |
6.9% |
| Alopecia Areata |
5.9% |
| Product Used For Unknown Indication |
5.9% |
| Premature Labour |
4.0% |
| Pruritus |
4.0% |
| Fungal Infection |
3.0% |
| Hypertension |
3.0% |
| Maternal Therapy To Enhance Foetal Lung Maturity |
3.0% |
| Bronchopulmonary Aspergillosis |
2.0% |
| Depression |
2.0% |
| Hepatitis C |
2.0% |
| Intertrigo |
2.0% |
| Neoplasm Malignant |
2.0% |
| Osteoarthritis |
2.0% |
| Pain |
2.0% |
| Rash |
2.0% |
|
| Maternal Drugs Affecting Foetus |
17.6% |
| Drug Exposure During Pregnancy |
14.7% |
| Skin Papilloma |
8.8% |
| Dizziness |
5.9% |
| Drug Ineffective |
5.9% |
| Maternal Exposure During Pregnancy |
5.9% |
| Acute Generalised Exanthematous Pustulosis |
2.9% |
| Cleft Palate |
2.9% |
| Cushing's Syndrome |
2.9% |
| Expired Drug Administered |
2.9% |
| Growth Retardation |
2.9% |
| Incorrect Drug Administration Duration |
2.9% |
| Intentional Drug Misuse |
2.9% |
| Kerion |
2.9% |
| Liver Function Test Abnormal |
2.9% |
| Oesophageal Variceal Ligation |
2.9% |
| Off Label Use |
2.9% |
| Paranoia |
2.9% |
| Pneumonia Staphylococcal |
2.9% |
| Pregnancy |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
40.1% |
| Drug Use For Unknown Indication |
6.0% |
| Pruritus |
5.4% |
| Gastroenteritis |
4.3% |
| Gastrooesophageal Reflux Disease |
4.0% |
| Hypertension |
4.0% |
| Nasopharyngitis |
3.9% |
| Insomnia |
3.7% |
| Upper Respiratory Tract Infection |
3.2% |
| Rash |
2.9% |
| Prophylaxis |
2.8% |
| Psoriasis |
2.7% |
| Breast Cancer |
2.5% |
| Metastases To Bone |
2.5% |
| Constipation |
2.3% |
| Diarrhoea |
2.3% |
| Hiv Infection |
2.1% |
| Rectal Cancer |
2.0% |
| Conjunctivitis |
1.9% |
| Pain |
1.6% |
|
| Epilepsy |
11.3% |
| Pneumothorax |
11.3% |
| Intestinal Obstruction |
7.3% |
| Urticaria |
6.7% |
| Breast Mass |
6.0% |
| Swollen Tongue |
6.0% |
| Wound Drainage |
6.0% |
| Pruritus |
5.3% |
| Vomiting |
4.0% |
| Zinc Deficiency |
4.0% |
| Dyspnoea |
3.3% |
| Hyperglycaemia |
3.3% |
| Liver Abscess |
3.3% |
| Rash |
3.3% |
| Renal Failure Acute |
3.3% |
| Type 2 Diabetes Mellitus |
3.3% |
| Unresponsive To Stimuli |
3.3% |
| Urinary Tract Infection |
3.3% |
| Acute Myeloid Leukaemia |
2.7% |
| Fatigue |
2.7% |
|
| Interacting |
| Computerised Tomogram |
100.0% |
|
|
